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Propranolol and pregnancy: Preliminary results of a prospective
study. Ph. Tcherdakoff C. Kreft, F. Berrard. Hdpital Ambroise
Pare, Bonlogne, France. Theoretically, beta-blockers may prove
harmful during pregnancy: there may be increase of uterine con-
tractions (risk of premature birth), fetal bradycardia, neo-natal
hypoglycemia. A preceding retrospective study seemed to mini-
mize these dangers. A prospective study with precise measure-
ments of uterine contractions, fetal cardiac rhythm, neonatal gly-
cemia, and APGAR index has been started in order to support the
initial data. Preliminary results, obtained from a small number of
patients, apparently show that the harmful effects of beta-blockers
during pregnancy are less important than initially thought.
Repeat biopsies in membranous glomerulonephritis (MGN). M.
Zanetti, L.H. Noel, C. Barbanel and D. Droz. Clinique Néphrolo-
gique et Service de Thérapeotique Néphrologique, Hbpital
Necker, Paris, France. Fourteen patients with MGN had repeat
biopsies. All but two had idiopathic MGN. All biopsies were
studied by light microscopy; 18 were examined by immunofluores-
cent and 13 by electron microscopy or on thin sections. Three
stages of lesions of the glomerular capillary wall were observed:
type I: diffuse presence of subepithelial deposits (SED) without
spikes; type II: presence of SED with diffuse spikes; type III:
complex morphological changes of the capillary wall. On the first
biopsy 7 patients were type I and 7 were type II. None had renal
insufficiency. Evolution: A) Complete pathological recovery
(three cases) was observed in two patients with type I and one with
type II lesions, 1.5, 4, and 5 years, respectively, after the first
biopsy. All patients had nonnal urinalysis and normal renal func-
tion at the time of the second biopsy. B) Three patients with type I
had unchanged lesions 6 months to 2 years after first biopsy.
Isolated proteinuria without renal failure persisted in two patients.
One had clinical remission. C) Change of type (eight cases): One
patient with type II lesions on the first biopsy had type I on a
second biopsy performed 10 years later and subsequently had
clinical remission. Two patients with type I on the first biopsy had
type III when re-biopsied after an interval of 3 and 6 years. One
developed renal insufficiency, the other had clinical remission.
Five patients with type lion the first biopsy showed type III on the
second biopsy. The intervals ranged from 6 months to 4 years after
the first biopsy. One developed end-stage renal failure, three had
clinical remission, and one had persistent nephrotic syndrome. In
conclusion, the change from type I through type III does not
always correspond to a progressive worsening of the clinical status
of the patient. All morphological types may change and lead to
complete pathological recovery.
Histopathological course in 55 cases of pregnancy nephropathy.
P. Zech, S. Colon, N. Blanc, M. Labeeuw, and J.P. Chalmet.
Clinique de Néphrologie et des Maladies Métaboliques, Hópital
Edonard Herr/at, Lyon, France. Fifty-five patients with persistent
abnormalities after pregnancy nephropathy (19 recurrent forms)
were studied by 60 renal biopsies performed from less than 3
months (19 cases) to more than one year (9 cases) after the onset of
the disease. Fifty single biopsies showed moderate glomerular
proliferation or cellular swelling, segmental hyaline sclerosis mi-
crohyalinosis, and frequent mesangial hyperplasia. Subentothelial
deposits, chiefly in the arterioles, appeared or increased with time.
Hyperplasia of the juxtaglomerular apparatus was occasionally
noted. Twenty-one immunofluorescent studies revealed arteriolar
C3 deposits in 40% (before 3 months), 58% (between 3 and 6
months), and 56% (after 6 months) of the cases. Except in early
biopsies, there was no glomemlar immune deposition. Fibrin de-
posits decreased with time. Serial biopsies (5 cases) showed a
decrease in the glomerular proliferation; mesangial hyperplasia
and segmental hyaline sclerosis remalned stable. Subendothellal
deposits were frequently seen, malnly on the arterioles, and hyper-
plasia of the juxtaglomerular apparatus occurred in one case. Five
early biopsies revealed vascular C3 deposits (2 cases) and glomer-
ular fibrin deposits (4 cases). C3 deposits were found on all late
biopsies. In conclusion, arteriolar lesions with C3 deposits were
the main findings of prognostic value. They might be correlated
with the subsequent rise of blood pressure, even without
proteinuria.
Transient hypercalcemia associated with Reiter's syndrome in
chronic dialysis patients. J. Zingraff, B. Amor, T. Dr//eke, N.K.
Man, P. Jangers, and J. Crosnier. Clinique Néphrologique, Hdpi-
tal Necker, and I.N.S.E.R.M. U.25, Paris, France. Reiter's syn-
drome, frequently associated with the presence of the intracellular
parasite, Chlamydia trachomatis A in urethral specimens, has
never been reported in dialysis patients. Four (about 10%) of our
hemodialysis patients experienced unexplainable episodes of fever
and acute arthralgias. Their association with conjunctivitis in all
and with urethritis in three orientated us to the diagnosis of
Reiter's syndrome. In all patients, intracellular inclusions highly
suggestive of Chlamydia were demonstrated (in urethral speci-
mens in three patients, in the conjunctiva in one). However, these
inclusions were not cultured. Lymphoblastic transformation in the
presence of a Chlamydia (ornithose-psittacose) antigen was nega-
tive in all, but the test was performed more than one year after the
onset of symptoms. Screening for specific serum antibodies is in
progress. Only one of the patients possessed HLA B27 phenotype.
Three of these four patients had transient elevation of plasma
calcium concentration during the acute phase of the syndrome
(predialysis plasma calcium > 11.5 mg/ 100 ml). This elevation
lasted for three to four weeks. The hypercalcemia might be related
to increased bone resorption due to inflammatory periostitis. A
comparable bone resorbing activity has recently been reported in
hypercalcemic patients with rheumatoid arthritis. To conclude,
the frequency of Reiter's syndrome may be underestimated in
hemodialysis patients. One should evoke this diagnosis when
unexplained fever, arthralgias and/or hypercalcemia complicate
the course of long-term dialysis treatment. Further investigations
on this syndrome should be completed by culture of the intracellu-
lar organism. A study of its epidemiologic distribution in dialysis
patients would be of great interest.
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Syndrome of inappropriate secretion of antidiuretic hormone
(SIADH) and cerebrovascular accidents. V. Beroniade, and A.
Farah. Department of Nephrology, Hotel-Dien de Montréal,
Montreal, Canada. The SIADH is frequently described as a com-
plication of cerebrovascular accidents, but to our knowledge,
there is no published study concerning its incidence and clinical
implications. In a series of 20 patients, we found hyponatremia and
hypoosmolality starting from the first to the fifth day in 15 patients.
The severity of the hyponatremia is not always remarkable; in one
case, however, the sodium plasma level decreased to 105 mEq/liter
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before therapeutic intervention, and values below 125 mEq/liter
are quite usual. The duration of the syndrome is usually from 5 to
10 days. In particular cases, it was prolonged up to 19 days. A
spontaneous remission with evidence of disappearance of the
SIADH occurred in all patients studied. It is worthwhile to men-
tion that in two patients in whom a fluid restriction was imposed
from the very beginning, the hyponatremia was blocked at 133 and
134 mEq/liter, respectively, but the urinary parameters still al-
lowed us to confirm the presence of SIADH. The therapeutic
approach was administration of furosemide and isotonic or hyper-
tonic saline or, simply, limitation of fluid intake, depending on the
severity of hyponatremia. The somnolence and lethargy of these
patients disappeared usually before the plasma sodium reached
130 mEqlliter. In conclusion, we think that the SIADH is a near
constant complication of cerebrovascular accidents. The preven-
tion of its dilutional effects or their treatment, once installed,
seems to be of value in the prophylaxis of cerebral edema, which
can contribute to the comatous state of these patients.
Thrombocytopenia, immunological tests, and disease activity in
lupus nephritis. W.F. Clark, A.L. Linton, P.E. Cordy, P.A.
Keown, R.C. Lohmann, and R.M. Lindsay. Department of Ne-
phrology, Victoria Hospital, St. Joseph's Hospital and University
Hospital, and Department of Haematology, Victoria Hospital,
London, Ontario, Canada. Twenty patients with the diagnosis of
lupus nephritis were followed with serial complement, ANA, C3,
C4, DNA binding, and platelet counts for a mean time of 34
months after renal biopsy. There were 25 episodes of nonhemato-
logic observed disease activity in 16 of the 20 patients, and an
elevated DNA binding and thrombocytopenia bore a good correla-
tion with these episodes. The mean platelet count determination
with observed disease activity was 96,000 42,000 and was
significantly different than the mean platelet count of 248,000
90,000 with disease quiescence. The rate of false positivity with
the immunologic tests varied from 25 to 71%, and for thrombocy-
topenia, 11%. It is suggested that a fall in platelet count may be a
simple and accurate index of disease activity in systemic lupus
erythematosus (SLE) nephritis; it is probably more reliable than
measurements of DNA binding or complement levels, perhaps
because platelets are important mediators of tissue damage in SLE
nephritis.
Effect of chronic hemodialysis on the RBC transport abnormal-
ity of uremia. C.H. Cole and S.C. Ventura. Department of Medi-
cine, McGill University, Montreal, Canada. Patients with un-
treated chronic renal failure have a decrease in erythrocyte
membrane sodium-potassium-ATPase activity, resulting in a de-
crease in the rate of sodium efflux from the erythrocyte. When
normal erythrocytes are incubated in the plasma of patients with
uremia, there is a decrease in the activity of Na-K-ATPase in these
erythrocytes. We have done detailed studies of erythrocyte so-
dium transport, using conventional flux techniques in a group of
hemodialysis (HS) patients, and we have found no abnormalities in
sodium transport. Red cell sodium concentration and Na-K-ATP-
ase activity were normal. Other flux studies (N = 5) were done in
the presence of plasma. The ouabain sensitive (os.) rate constant
for sodium effiux was identical (0.138) in both patients and con-
trols. Additional studies (N = 9) were done in which erythrocytes
from normal controls were incubated in the plasma of HD patients
and in the plasma of other controls. Following a two-hour pre-
incubation period, sodium efflux studies were done in the presence
of the respective plasma. The mean rate constant for sodium efilux
was 0.202 0.009 inthe presence of HD plasmaand 0.191 0.009
in the presence of control plasma. The o.s. rate constant was 0.114
0.009 and 0.105 0.008, respectively. No difference was found
in the total amount of sodium pumped (1.50 0.10mmoles/liter of
RBC per hr for controls cells incubated in HD plasma vs. 1.42
0.10 mmoles/liter of RBCIhr for control cells incubated in control
plasm) nor in the o.s. pump. We conclude that chronic HD re-
moves the toxic factor which is responsible for abnormalities of
RBC transport in uremia. Such studies may be of use in assessing
the adequacy of long term hemodialysis.
Polymyositis, arthritis, and glomerulonephritis: A new overlap
syndrome? R.F. Dyck, C.J. Cardella, A. Katz, M. Johnson, M.
Silverman, D. A. Gordon, Z. Shainhouse, andR. A. Bear. Depart-
ments of Medicine and Pathology, University of Toronto, Toronto.
Four patients (21 to 41 yr) presented with symmetrical limb girdle
weakness and polyarthritis, myalgias, recurrent fever, and protein-
uria. CPK, LDH, and SGOT levels were elevated in each case,
and the diagnosis of polymyositis was confirmed by electromyo-
graphy and muscle biopsy. Raynaud's phenomenum and sacroille-
itis each occurred in one case. No patient had an underlying
neoplasm or a second collagen vascular disease. Rheumatoid fac-
tor was negative in three cases and weakly positive in one. Antinu-
clear factor was negative in all patients; cryoglobulins, LE prepa-
rations, and ASO titers were absent or normal in three patients
tested. C3 complement level was decreased in one case. BUN and
serum creatinine were normal in each patient; however, the 24-hr
urine protein excretion ranged from 1.7 to 4.2 g. Two patients had
an active urine sediment, and one had myoglobinuria. Renal biop-
sies (three patients) showed a mild focal segmental mesangial
increase. Immunofluorescence was negative in one biopsy and
mildly positive for IgC and 1gM in another. All patients were
treated with high dose steroid therapy; in each case, there was a
rapid improvement in polymyositis, and arthritis and proteinuria
disappeared. In the present report, we describe four patients with
idiopathic glomerulonephritis in association with polymyositis. To
our knowledge this relationship has not been emphasized previ-
ously. The pathogenesis of this new disease complex remains to be
determined.
Urinary lysosomal enzyme levels after renal allotransplantation:
An indicator of acute rejection. R.F. Dyck, C.J. Cardella, and
MA. Sacks. The Gage Research Institute and Division of Ne-
phrology, Toronto Western Hospital, Toronto. Three urinary lyso-
somal enzymes, /3-glucuronidase (/3-gluc), /3-galactosidase (/3-gal),
and N-acetyl-/3-D-glucosaminidase (NAG), were measured in re-
nal allograft recipients to evaluate their role as indicators of rejec-
tion in the early posttransplant period. A fluoremetric assay using
methylumbelliferone (MU) substrates was used to measure the
three enzymes in morning urine samples collected under sterile
conditions. A unit (U) of enzyme activity is expressed as 1 nmole
of MU liberated per hour incubation per mg of urine creatinine.
Eighteen rejection episodes occurred in 14 patients who were
studied for up to 53 days posttransplantation. A rejection episode
is defined as a significant rise in the serum creatinine above
baseline. Urinary NAG levels were elevated in all 18 rejections
(100%). In 12 of these (67%), NAG increased before the rise in
serum creatinine. /3-gal rose before or during 10 rejection episodes
(56%), while elevations in /3-gluc parallelled only 7 such events
(39%). Urinary enzyme levels did not distinguish prolonged early
acute tubular necrosis from rejection (two patients). The combina-
tion of NAG (> 1400 U) and low values of /3-gal and /3-glue
occurred only with complete graft infarction (two patients). The
measurement of urinary lysosomal enzymes is a rapid and simple
adjunct to the diagnoses of graft rejection and infarction in the
early posttransplant period.
Effect of renal microvascular obstruction on renal vascular tone.
H. Fung, G. Ayotte, D. Jones, and A. Thomson. Department of
Medicine, University of Manitoba, Winnipeg, Manitoba. Changes
in renal vascular tone are not accurately reflected by changes in
whole kidney vascular resistances when undetermined portions of
the vascular pathway are obstructed. In this study, we have used
the renal blood flow (RBF) responses to a vasodilator, acetylcho-
line (ACH), and a vasoconstrictor, norepinephnne (NE), to assess
renovascular tone before and after renal microvascular obstruction
in the dog. Thirty-two mongrel dogs weighing 18—27 kg were
studied under pentobarbitol anesthesia. The renal artery was cath-
eterized via the femoral artery, aided by fluoroscopy. Total RBF in
response to incremental intraarterial (IA) infusions of ACH and
NE was measured using electromagnetic flow probes before and
after microvascular obstruction. Obstruction was produced by
serial IA bolus injections of carbonized microspheres. Three sizes
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of spheres were used in three groups of dogs: 15 , 35 s, and 50
in diameter, producing approximately 50% reduction in RBF.
Glomerular capillary obstruction by 15-s spheres resulted in a
marked shift of the ACH dose-response curve to the right. RBF
responses to NE were shifted to the left. In contrast, arteriolar
obstruction by 50-jz spheres resulted in leftward shifts of the ACH
response, with diminished sensitivity to NE. Embolization using
35-p spheres resulted in intermediate responses. In addition, RBF
increased in response to low-dose 15-p. microsphere embolization.
This was abolished by pretreatment with indomethacin (20 mg/kg).
These observations suggest that arteriolar obstruction resulted in
vasoconstriction in the remaining patent vessels, whereas glomer-
ular capillary obstruction resulted in vasodilatation. The latter may
be partly mediated by prostaglandin release.
Infrared analysis (IR) of urinary tract calculi. H. Gault, W.
Cohen, C. Eustace, D. Churchill, and I. Senciall, Departments of
Medicine and Laboratory Medicine, The General Hospital and
Memorial University, St. John's, Newfoundland. Analysis of cal-
culi by IR, using the system of interpretation of Oliver and Sweet,
was compared with wet chemical analysis (WC). Thirty-seven
percent of 111 calculi weighed less than 15 mg, an amount which is
insufficient for complete WC. Sixty calculi were analyzed indepen-
dently using IR by two individuals; there were three disagree-
ments, all relating to the possible presence of a trace amount of a
single compound. Comparison of analyses of 31 calculi by WC and
JR gave complete agreement in 14; oxalate was the compound
most frequently missed by WC (in 6). Analysis of 17 calculi using
WC by two operators independently, considering seven compo-
nents, gave complete agreement for six. Five calculi were studied
blind in quadruplicate and one on eight occasions by IR; there was
one disagreement. Seven compounds in five calculi were studied
blind on three occasions by WC; there were 13 discrepancies.
Minimum detectable amounts of single pure compounds by JR
analysis varied within one order of magnitude, compared with a
range of 10 for WC. Of 100 patients, 47 had stones composed (IR)
of calcium oxalate, with or without a trace of phosphate. We have
confirmed that JR using the technique of Oliver and Sweet is a
simple, sensitive, and reproducible method. As only one milligram
is required, JR permits analysis of many calculi not possible by
standard WC methods. The relatively uniform sensitivities for
common components with IR, compared with WC, permit a semi-
quantitative approach.
Variables influencing outcome in a series of donor pretreated
cadaver allografts. R.D. Guttmann, D.D. Morehouse, J.M. Meak-
ins, J. Klassen, J.G. Beaudoin, and J. Knaack. Transplantation
Service, Royal Victoria Hospital and McGill University, Mon-
treal, Quebec. In a single center unselected nonexclusion series of
78 consecutive cadaver renal allografts in 76 recipients, using
kidneys obtained from donors who were pretreated with large
doses of cyclophosphamide and methyiprednisolone, excellent
clinical results with a two-year graft survival of 70% and a five-
year survival of 66% have been obtained. Patient survival was 92%
at two and five years. The improvement in results is believed in
large part to be contributed to by the reduction in allograft immu-
nogenicity due to short-term donor pretreatment. In this series,
poor tissue matching grades were notable, 36 patients were not
transfused, 33 patients were high risk, and 43 patients were presen-
sitized. In spite of these negative selection factors, the results
obtained in this pretreated series had 18% of graft losses due to
rejection and other losses due to technical failures and recurrent
disease. Further analysis shows that other variables which must be
considered in outcome are pretransplant transfusions, length of
dialysis, original disease, pretransplant nephrectomy, anergy, and
length of function of a previous transplant, in addition to age, sex,
and risk status. Thus, not only does selection of patients influence
results, in addition to the pre- and post-transplant immunosuppres-
sive regimen, but these observations suggest that at least 10 varia-
bles must be matched for in any control1ed" study designed to
elucidate whether any one factor is beneficial or detrimental to the
outcome.
Renal sarcoidosis: Clinical features and natural history of five
cases. S. Handelsman, K.Y. Lee, D. Cattran, D. Wilson, M.
Johnson, and R.A. Bear. University of Toronto, Toronto, Canada.
In the present report, we describe five cases of renal sarcoidosis.
All patients were male, ranged in age from 29 to 62 yr (mean, 40
yr), and presented with renal failure of unknown origin along with
clinical features such as weight loss, anemia, arthritis, hepatome-
galy, lymphadenopathy, nonproductive cough, hypertension,
polyuria, and polydypsia. In each case the diagnosis of sarcoidosis
was confirmed by liver andlor lymph node biopsy, and in each case
renal involvement was documented by renal biopsy. Serum creati-
nine at time of presentation ranged from 3 to 15 mg/dl (mean, 8.0).
All patients were episodically hypercalcemic, 24-hr urine calcium
excretion was increased in each of three cases in which it was
measured, and renal calculi were present in two cases. Renal
biopsy uniformly revealed nephrocalcinosis with interstitial ne-
phritis and tubular atrophy, and in three cases noncaseating granu-
lomata were present. Steroid therapy led to rapid improvement in
renal function (mean posttreatment serum creatinine, 3.1 mg/dl),
accompanied by decreased serum and urine calcium levels. Patient
follow-up ranged from 1 to 8 yr (mean, 3.6). In three cases,
hypercalcemia and worsened renal function accompanied steroid
withdrawal and improved with its reinstitution. Renal sarcoidosis
is not rare and may be the presenting feature of sarcoidosis. It is
characterized by hypercalcemia, hypercalciuria, and interstitial
and granulomatous renal disease. Long-term steroid therapy is
effective in reversing hypercalcemia and preserving renal function.
Relapses may occur, and patient follow-up is essential.
Non-steady state mathematical model of acute renal failure. A.
Hag, E. Hew, A. Aberman, and M. Goldstein. University of
Toronto Departments of Medicine & Anesthesiology, Mount Sinai
and St. Michael's Hospitals, Toronto, Canada. We have devel-
oped a non-steady state mathematical model to describe creatinine
(Cr) behavior during acute renal failure. The model is based on two
assumptions: Cr is distributed equally in total body water, and
changes in Cr clearance (Ccr) occur instantaneously. The model is
designed to allow for changing rates of Cr production that may
occur in acute renal failure. Unlike previous models of acute renal
failure, this model uses a first order differential equation to calcu-
late the changes in Cr as a function of time. The model has clinical,
research, and educational applications. Given any two serum Cr's
and the interval urine Cr, the Cr production rate and Ccr is first
calculated, and then, the serum Cr at any specified future time and
any future 24-hr urine Cr can be predicted. Also, if a serum Cr is
specified, the time when it will be attained can be calculated. Any
number of changes in Ccr or Cr production rate can be accepted.
We have tested the model with data from five patients with renal
failure. Using this model, we have written and implemented a
computer program on a mini-computer in our ICU which we have
found useful in understanding the changes in Cr behavior in criti-
cally ill patients with renal failure.
A prospective randomized study of cadaver donor pretreatment:
Preliminary report. J. R. Jeffrey, A. Downs, J. W. Grahame, C.
Lye, E. Ramsey, and A. E. Thomson. Transplant Program, Health
Sciences Centre and University of Manitoba, Winnipeg, Canada.
To determine the effect of cadaver donor pretreatment (PreRx) on
graft survival, we have randomly assigned donors to PreRx or No-
PreRx groups since July 1975. PreRx consisted of an iv. infusion
of 5 g of niethylprednisolone (MP) and 7 g of cyclophosphamide
(CY), given at least four hours before nephrectomy. Immuno-
suppression consisted of prednisone, azathioprine (AZ), MP infu-
sions routinely and for rejections, with or without CY on a random
basis. In the PreRx group, 12 patients (Pt) had received transfu-
sions, six had> 10% cytotoxic antibodies, and the mean antigen
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Pt at risk 22
Pt survival, % 22000)
Graft survival, 9k 14(63.6)
Creatinine 1.5 0.3
Rejections 2.3 0.8
Prednisone, g 13.1 3.8
AZ, g 10.5 2.8
16
16(100)
8(50.0)
2.0 0.9
3.6 1.8
21.4 5.3
50.4 6.4
30
28(93. 3)
21(70. 0)
1.5 0.5
1.9 1.1
11.7 2.8
10.7 2.6
19
16(84. 2)
12(63.2)
1.6 0.5
2.4 2.4
18.6 5.3
47.5 7.0
match was 1.36 0.95. Respective figures for the No-Prekx group cium and ionized calcium (Ca) concentnstions in non-cirrhotic
are 15, 6, and 1.40 0.89. Posttransplant results are: hypoalbuminemic patients (including nephrotics). Ca was mea-
Pretreatment No pretreatment
sured both in whole blood (containing 10 U/mI heparin) and in
serum, and was significantly higher in the serum (serum Ca =
3 months 12 months 3 months 12 months 0.85 x whole blood Ca + 0.39, r = 0.96). In 12 non-cirrhotic
patients with serum albumin concentrations between 1.0 and 3.3 g/
100 ml, and Ca between 3.2 and 4.3 mgIlOO ml, the relationship
between the total serum calcium and albumin was: Ca = 0.30 ><
albumin (g/l00 ml) + 7.75 (r = 0.50). the relationship between
bound serum calcium (total calcium minus Ca) and albumin
concentration was: bound Ca = 0.17 >< albumin (g/l00 ml) + 4.26(r = 0.40), indicating very little change in the concentrafion of
bound calcium over a wide range of albumin levels. Thus in these
hypoalbuminenic patients, bound (non-ionized) calcium concen-
The creatinine, rejections, and prednisone values are the mean
1 SD. None of the results are significantly different. These
results do not demonstrate any beneficial effect of cadaver donor
trations are higher than would be anticipated from their albumin
concentrations, suggesting either an increase in the affinity of
albumin for calcium or increased calcium binding by other anions.
pretreatment on patient or graft survival.
Influence of exchange volume and dialysate flow rate on solute
Furosemide and normal saline in the treatment of the syndrome
of inappropriate ADH. R.D. Kinloch, W.F. Clark, R.M. Lindsay,
and AL. Linton. Department of Medicine, Victoria Hospital,
London, Ontario, Canada. Five patients with documented syn-
drome of inappropriate ADH secretion associated with hyponatre-
mia < 120 mEq/liter and signs of cerebral dysfunction were treated
with i.v. ftirosemide and isotonic saline. The urine sodium and
serum sodium levels were closely monitored and treatment was
discontinued after achieving a serum sodium of> 130 mEq/liter.
All patients exhibited a rapid clinical and biochemical recovery
using this form of therapy. This method proved to be a simple
effective regimen for treating patients with the syndrome of map-
propriate ADH secretion associated with cerebral dysfunction.
clearance in peritoneal dialysis. M. Robson, D.G. Oreopoalos, S.
Izatt, R. Ogilvie, A. Rapoport, and G.A. deveber. Toronto West-
em Hospital, Toronto Ontario, Canada. In order to find the ideal
dialysate flow rate and exchange volume for use in long term
peritoneal dialysis, 10 patients were studied over a period of 1.5 yr.
Exchange volumes of 1 or 2 liters and dialysate flow rates of 1, 2,
3, 4, and 6 liters/hr were tested. Dextrose concentration remained
constant at 1.5 g/100 ml. Peritoneal clearances for BUN, creati-
nine, and uric acid were calculated at 2, 5, 10, 15, and 20 hr during
dialysis, making a total of 120 clearances for each patient. All
patients used a reverse osmosis automatic machine. The clear-
ances of all three solutes tended to be higher with exchange
volumes of 2 liters than with 1 liter; this trend was significant for
BUN (P <0.025) and uric acid (P <0.025) but not for creatinine.
There was a significant rise in clearance with increasing flow rates
Platelet factor 4 activity in patients on maintenance hemodialy- per hour for all solutes as shown in the following table.
sis. R.M. Lindsay, A. Aronstam, B. Dennis, M.J. Friesen, W.F.
Clark, and A.L. Linton. University of Western Ontario, London,
Ontario, Canada. Platelet release is impaired in uremia and is only
partially improved by dialysis. Nevertheless, the platelet-dialysis
membrane interaction is implicated in thrombus formation during
dialysis. Faced with this paradox, we studied the levels of plasma
platelet factor 4 (PF4) in 22 dialysis patients (group A) and com-
pared these with levels in 12 normal subjects (group B), in 10 non-
dialyzed patients with advanced chronic renal failure (group C)
and in six patients with normal renal function who had been
exposed to the extra-corporeal circulation of the heart lung bypass Since patients could not tolerate a flow rate of 5 liters/hi, we
(group D). PF4 was measured biologically, estimating the heparin conclude that a flow rate of 4 liters/hr with a 2-liter exchange will
neutralizing activity (HNA) of plasma. PF4 levels were signifl- give maximum efficiency.
cantly elevated in group A (0.089 0.02 U/mi; mean su) as
compared with groups B (0.065 0.01), C (0.069 0.02), and D
(0.069 0.02). The PF4 levels were found to be correlated with the
velocity of ADP-induced (2.5 mM) platelet aggregation (r = 0.82;
P < 0.01), suggesting that plasma HNA was related to platelet
content release. Furthermore, impaired release of PF4 from plate-
lets of dialysis patients was demonstrated. It is postulated that the
trauma of extracorporeal circulations causes platelets to release
PF4 which is not cleared by the dialysis membranes of the artificial
kidney but is cleared by the human kidney. Although dialysis
patients have impaired platelet PF4 release, the mass effect is to
increase circulating HNA. This has therapeutic implications for
heparin dosage schedules during hemodialysis.
Coexistence of distal renal tubular acidosis and nephrogenic
diabetes insipidus in two patients: Implications for the pathogen-
esis of distal renal tubular acidosis. W.L.M. Robson, A.O. Folami,
J.W. Ba/fe, B.J. Stinebaugh, and M.L. Ha/penn. Departments of
Pediatrics and Medicine, University of Toronto, Toronto, Canada,
and Bay/or College of Medicine, Houston, Texas, U.S.A. Two
cases with the combination of distal renal tubular acidosis and
nephrogenic diabetes insipidus are presented. The former diagno-
sis was based upon a urine pH of 6.9 during acute metabolic
acidosis (blood pH of 7.21 and 7.01; bicarbonate, 14 and 7 mEq/
liter, respectively), a normal bicarbonate threshold, and a low
urine minus blood Pco2 gradient in alkaline urine when compared
to controls excreting urine with similar bicarbonate and phosphate
Sernm ionized calcium in hypoalbuminemic patients. J.P. Lou-
werens and R.A.L. Sutton. Department of Medicine, University of
concentrations. The diagnosis of nephrogenic diabetes insipidus
was established when the maximum osmolality of the urine (180
British Columbia, Vancouver, British Columbia. In both normal and 122 mOsm/liter) was less than that of the blood after antidi-
subjects and hypoalbuminemic cirrhotic patients, a relationship uretic hormone infusion. The serum potassium concentration was
between serum albumin and total calcium has been reported, 3.2 and 3.5 mEq/liter in the two patients. The urine osmolality rose
which suggests that 0.7 to 1.0 mgllOO ml of calcium are bound to to 900 mOsm/liter when this antidiuretic hormone preparation was
1.0 g/l00 ml of albumin. We have used the Orion SS2O automated administered to control subjects. The coexistence of these two
calcium electrode to examine the relationship between total cal- disorders lends support to the hypothesis that the pathogenesis of
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distal renal tubular acidosis in these patients is due to a decrease in
collecting duct hydrogen ion secretion rather than to increased
permeability of their collecting ducts to carbonic acid and hydro-
gen ions.
Relationship between congenital anomalies of the urinary tract
and HLA haplotyping. D.P. Sengar, A. Rashid, and N. Walfish.
Department of Medicine and Pediatric, University of Ottawa and
Ottawa General Hospital, Ottawa, Ontario, Canada. Congenital
anomalies of the urinary tract, such as ureteric refiux, ureteric
dilation or stenosis, may cause serious kidney diseases and even-
tual renal failure. Although such anomalies have been known to
occur in more than one member of a family, their genetic transmis-
sion has not been clearly defined. We studied 3t members of four
families for ureteric stenosis (one family of 15 members) and
ureteric refiux (three families of at least five members each).
Minimum urologic investigations included an IVP, a cystoseopy,
and a voiding cystogram. Every member of each family were
tissue-typed for all known HLA specifities. The genetic analysis
also included the determination of ABO blood group genotyping
and haplotyping. Thirty to fifty percent of the family members in
each family had developmental urinary tract abnormalities. In all
four families, a complete segregation of the anomalies was found
with HLA haplotype. The haplotype came from the mother in
three families, and from the father in one. It was transmitted to
both sexes with varying degree of genetic penetration (severity of
the anomalies). We feel that some of the urinary tract anomalies
are genetically transmitted and that HLA haplotyping may be
helpful as a marker for the transmission of these anomalies within
a family.
